Herbert Lepor, MD, and Danil Makarov, MD, MHS explain a case in which a patient experiences a rising PSA but has had two biopsies preformed with negative results. Lepor…
NEW YORK (Reuters Health) – Survival among women diagnosed with breast cancer when they are pregnant is comparable to that for nonpregnant women of reproductive age treated for…
Some pregnant women express concerns over the possibility of pain, vaginal tearing and other risks for themselves and their children. A cesarean delivery on maternal request (CDMR) may not always…
Herbert Insel, MD, and Clinical Instructor at NYU Langone Medical Center, talks about the latest research on the health benefits of the Mediterranean Diet. He explains the the diet…
Zachary Bloomgarden, MD, Clinical Professor at Mount Sinai Hospital, discusses goals for a 61-year-old male with rising levels of HbA1c and fasting glucose. He delves into the 2013 AACE…
NEW YORK (Reuters Health) – A meta-analysis of 25 studies has confirmed an increased risk of cancer among children born after fertility treatment. However, “Our results do not…
Leonardo Pignataro, PhD, delves into the latest research on neuroscience and alcohol consumption. Pignataro’s research shows that even small quantities of alcohol affect gene expression through regulation of…
Martin E. Gordon, MD, former professor at the Yale School of Medicine, and CEO of Medical Films, talks about his latest project: Planting the Diagnosis, an app that gives…
Age-related macular degeneration accounts for more than half of all blindness in the United States. Past studies have shown that taking a formulation of oral vitamins and minerals…
This month in Discussion in Diabetes, Steve Edelmen, MD, and Jeremy Pettus, MD, delve into continuous glucose monitoring, a new innovation for patients with Type 1 and Type…
As a 24 year old journalist in NYC, Susannah Cahalan was used to dealing with tough situations, but nothing could have prepared her for the life or death battle she…
NEW YORK (Reuters Health) – A European study indicates that patients with T-cell prolymphocytic leukemia may respond well to induction chemotherapy using fludarabine, mitoxantrone and cyclophosphamide, followed by…
